Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

PAPE STRATEGIES AND PERFORMANCE IN MALE KICKBOXERS (PAPE-KB)

8 de noviembre de 2026 actualizado por: Halil UÇAR, Inonu University

Acute Effects of Different PAPE Applications on Agility and Explosive Performance in Male Kickboxers

This study aims to investigate the acute effects of different post-activation performance enhancement (PAPE) strategies on agility and explosive performance in male kickboxers. Twenty trained male kickboxers will participate in a single-group, repeated-measures experimental study involving four conditions: plyometric jumps (PLY), heavy squats (HS), isometric squats (ISO), and control (CON). The effects of these conditions will be evaluated using countermovement jump (CMJ) height, relative peak power, and the Illinois Agility Test. All four conditions will be performed in a randomized order, with a minimum washout period of 72 hours between sessions.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

This study was designed as a single-group, repeated-measures experimental study to investigate the acute effects of different conditioning activities on agility and explosive performance in male kickboxers.

Twenty trained male kickboxers aged 18-24 years will participate in the study. All participants will have at least three years of licensed sporting experience and an active training and competition background.

Following anthropometric assessments and a familiarization session with the Illinois Agility Test, participants will complete four experimental conditions in a randomized order: (1) Plyometric Jump (PLY), (2) Heavy Squat (HS), (3) Isometric Squat (ISO), and (4) Control (CON). A minimum washout period of 72 hours will be provided between sessions. To minimize circadian variation, all sessions for each participant will be conducted at approximately the same time of day.

Each experimental session will begin with a standardized five-minute warm-up consisting of three minutes of light jogging and two minutes of dynamic lower-limb mobilization exercises.

In the PLY condition, participants will perform three sets of five drop jumps from a platform height of 30-40 cm, emphasizing maximal explosive effort and short ground contact time.

In the HS condition, participants will perform one set of three back squats at 90% of their individually determined one-repetition maximum (1RM), with a knee flexion angle of approximately 90 degrees.

In the ISO condition, participants will perform three sets of 30-second wall-supported isometric squats, maintaining approximately 90 degrees of knee flexion, with one minute of passive recovery between sets.

In the CON condition, participants will complete the same standardized warm-up but will not perform any additional conditioning activity. A six-minute passive recovery period will follow the warm-up.

Following each conditioning activity, participants will complete a six-minute passive recovery period before performing two maximal countermovement jump (CMJ) trials. The highest jump height will be used for analysis. Relative peak power will also be recorded using the My Jump Lab application.

After a three-minute passive recovery period, participants will perform the Illinois Agility Test once under each condition. Completion time will be recorded using a dual-beam photocell timing system.

All sessions will be conducted under standardized indoor conditions. Participants will be instructed to avoid intense lower-limb exercise during the 24 hours before each session, caffeine consumption during the preceding 12 hours, and alcohol consumption during the preceding 48 hours.

The study will compare CMJ height, relative peak power, and Illinois Agility Test performance across the four experimental conditions to determine the acute effects of different PAPE strategies.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

20

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 24 años (Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Masculino

Descripción

Inclusion Criteria:

  • Male kickboxers aged 18-24 years.

At least three years of licensed sporting experience.

Previous success in international competitions.

Actively participating in training and competitions.

Willingness to participate in the study.

Exclusion Criteria:

  • Individuals who do not meet the specified inclusion criteria.

Individuals unable to complete the experimental testing procedures.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Control

Participants will complete the standardized five-minute warm-up but will not perform any additional conditioning activity. This will be followed by six minutes of passive recovery.

Experimental: Plyometric Jump (PLY)

Participants will perform three sets of five drop jumps from a platform height of 30-40 cm, emphasizing maximal explosive effort and short ground contact time.

Participants will perform three sets of five drop jumps from a platform height of 30-40 cm. Each jump will be performed with maximal explosive effort, emphasizing a rapid transition from landing to take-off and minimizing ground contact time.

Experimental: Heavy Squat (HS)

Participants will perform one set of three back squats using a load corresponding to 90% of their individually determined one-repetition maximum (1RM), with a knee flexion angle of approximately 90 degrees.

Participants will perform one set of three back squats using a load corresponding to 90% of their individually determined one-repetition maximum (1RM). Squats will be performed to a knee flexion angle of approximately 90 degrees.

Experimental: Isometric Squat (ISO)

Participants will perform three sets of 30-second wall-supported isometric squats, maintaining approximately 90 degrees of knee flexion, with one-minute passive recovery intervals between sets.

Participants will perform three sets of 30-second wall-supported isometric squats, maintaining a knee flexion angle of approximately 90 degrees, with one-minute passive recovery intervals between sets.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Illinois Agility Test Performance
Periodo de tiempo: Immediately after the 6-minute passive recovery period following the assigned conditioning activity.

Agility performance will be assessed using the Illinois Agility Test. Participants will complete the standardized 10 × 5 m course as quickly as possible. Completion time will be recorded in seconds using a dual-beam photocell timing system with a measurement precision of 0.01 seconds. Lower completion times indicate better agility performance.

Immediately after the 6-minute passive recovery period following the assigned conditioning activity.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

1 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

8 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

8 de noviembre de 2026

Publicado por primera vez (Actual)

16 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

8 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • INU-ARCH-2026-02

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .